Novel Preparation Methods of 52Mn for ImmunoPET Imaging
journal contributionposted on 2015-10-21, 00:00 authored by Stephen A. Graves, Reinier Hernandez, Jesper Fonslet, Christopher G. England, Hector F. Valdovinos, Paul A. Ellison, Todd E. Barnhart, Dennis R. Elema, Charles P. Theuer, Weibo Cai, Robert J. Nickles, Gregory W. Severin
52Mn (t1/2 = 5.59 d, β+ = 29.6%, Eβave = 0.24 MeV) shows promise in positron emission tomography (PET) and in dual-modality manganese-enhanced magnetic resonance imaging (MEMRI) applications including neural tractography, stem cell tracking, and biological toxicity studies. The extension to bioconjugate application requires high-specific-activity 52Mn in a state suitable for macromolecule labeling. To that end a 52Mn production, purification, and labeling system is presented, and its applicability in preclinical, macromolecule PET is shown using the conjugate 52Mn-DOTA-TRC105. 52Mn is produced by 60 μA, 16 MeV proton irradiation of natural chromium metal pressed into a silver disc support. Radiochemical separation proceeds by strong anion exchange chromatography of the dissolved Cr target, employing a semiorganic mobile phase, 97:3 (v:v) ethanol:HCl (11 M, aqueous). The method is 62 ± 14% efficient (n = 7) in 52Mn recovery, leading to a separation factor from Cr of (1.6 ± 1.0) × 106 (n = 4), and an average effective specific activity of 0.8 GBq/μmol (n = 4) in titration against DOTA. 52Mn-DOTA-TRC105 conjugation and labeling demonstrate the potential for chelation applications. In vivo images acquired using PET/CT in mice bearing 4T1 xenograft tumors are presented. Peak tumor uptake is 18.7 ± 2.7%ID/g at 24 h post injection and ex vivo 52Mn biodistribution validates the in vivo PET data. Free 52Mn2+ (as chloride or acetate) is used as a control in additional mice to evaluate the nontargeted biodistribution in the tumor model.
macromolecule PETvivo 52 Mn biodistribution validatessilver disc support52 Mn productionRadiochemical separation proceeds52 Mn recoverybioconjugate applicationchelation applications4 T 1 xenograft tumorspeak tumor uptakeCr targetpositron emission tomographyDOTA16 MeV proton irradiationMEMRIImmunoPET Imaging 52Mn52 Mnnontargeted biodistributionvivo images0.24 MeVanion exchange chromatographytoxicity studiesvivo PET datatumor modelchromium metalIDNovel Preparation Methodsresonance imaging60 μ24 h post injectionseparation factor